Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Nicole E, James"'
Autor:
Payton De La Cruz, Julia McAdams, Melanie Morales Aquino, Aileen I. Fernandez, Andrew Elliott, Maryam Lustberg, Christoph Schorl, Jennifer R. Ribeiro, Nicole E. James
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-19 (2024)
Abstract Background Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. While PD-1 based immunotherapies overall have led to improved treatment outcomes for this disease, a diverse response to frontline chemotherapy
Externí odkaz:
https://doaj.org/article/d70bfb940b8c4a6e827519886136689e
Autor:
Julia McAdams, Jasmine Ebott, Corinne Jansen, Chloe Kim, Daniela Maiz, Joyce Ou, Linda C. Hanley, Payton De La Cruz, Nicole E. James
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-12 (2024)
Abstract Background High grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy in which patients have still yet to respond meaningfully to clinically available immunotherapies. Hence, novel immune targets are urgently needed.
Externí odkaz:
https://doaj.org/article/31699427513a4cbe853e00abe9374970
Autor:
Nicole E. James, Morgan Woodman, Payton De La Cruz, Katrin Eurich, Melih Arda Ozsoy, Christoph Schorl, Linda C. Hanley, Jennifer R. Ribeiro
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The high rate of ovarian cancer recurrence and chemoresistance necessitates further research into how chemotherapy affects the tumor immune microenvironment (TIME). While studies have shown that immune infiltrate increases following neoadjuvant (NACT
Externí odkaz:
https://doaj.org/article/ffd7c0e3d4c44cefbef788522e4cad8f
Autor:
Nicole E. James, Jenna B. Emerson, Ashley D. Borgstadt, Lindsey Beffa, Matthew T. Oliver, Virginia Hovanesian, Anze Urh, Rakesh K. Singh, Rachael Rowswell-Turner, Paul A. DiSilvestro, Joyce Ou, Richard G. Moore, Jennifer R. Ribeiro
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Epithelial ovarian cancer (EOC) is a highly lethal gynecologic malignancy arising from the fallopian tubes that has a high rate of chemoresistant recurrence and low five-year survival rate. The ovarian cancer biomarker HE4 is known to promot
Externí odkaz:
https://doaj.org/article/1e2034decd7b4213a5c0a5824478d5c9
Autor:
Nicole E. James, Katherine Miller, Natalie LaFranzo, Erin Lips, Morgan Woodman, Joyce Ou, Jennifer R. Ribeiro
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy worldwide, as patients are typically diagnosed at a late stage and eventually develop chemoresistant disease following front-line platinum-taxane based therapy. Only modest res
Externí odkaz:
https://doaj.org/article/7845a4052e6d4d61941d67d8b61f0519
Publikováno v:
HPB. 24:1223-1237
Surgery for patients with pancreatic cancer carries a high risk of major post-operative complications and only marginally improves overall survival. This review aims to assess the impact of surgical resection on health-related quality of life (HRQOL)
Autor:
Nicole E. James, Matthew T. Oliver, Jennifer R. Ribeiro, Evelyn Cantillo, Rachael B. Rowswell-Turner, Kyu-Kwang Kim, Clinton O. Chichester, Paul A. DiSilvestro, Richard G. Moore, Rakesh K. Singh, Naohiro Yano, Ting C. Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
While selective overexpression of serum clinical biomarker Human epididymis secretory protein 4 (HE4) is indicative of ovarian cancer tumorigenesis, much is still known about the mechanistic role of the HE4 gene or gene product. Here, we examine the
Externí odkaz:
https://doaj.org/article/1d40d022ef174c3eb530873e0bececed
Publikováno v:
Oncogene. 41:1389-1396
Autor:
Nicole E. James, Eliana Kalakouti, Swathikan Chidambaram, Tamara M. H. Gall, Mikael H. Sodergren
Publikováno v:
Patient Reported Outcomes and Quality of Life in Surgery ISBN: 9783031275968
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52721c0a7bc2ff575202b8077d855962
https://doi.org/10.1007/978-3-031-27597-5_9
https://doi.org/10.1007/978-3-031-27597-5_9
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Human epididymis protein 4 (HE4) is an important clinical biomarker used for the detection of epithelial ovarian cancer (EOC). While much is known about the predictive power of HE4 clinically, less has been reported regarding its molecular role in th
Externí odkaz:
https://doaj.org/article/2d43a1a15e30414f90acd76e2019dd67